The company intends to focus on custom partnerships around stroke, cancer, cardiovascular diseases and neurodegenerative diseases.

At the Association for Molecular Pathology annual meeting in Boston, stakeholders discussed regulatory and legislative priorities for the coming year.

The Salt Lake City company said it has made "meaningful progress" on payor initiatives such as a pilot project in Nevada that is currently enrolling Medicaid patients.

Labcorp will acquire outreach labs serving patients in Indiana and northwest Ohio while Parkview will continue to operate labs serving acute and emergency needs.

Given the amount of tests that have required certification under the new system, the EU has staggered the grace periods for different classes of devices already holding CE-IVD marks obtained under the ...

The updated CE marking now enables labs in Europe to unify their workflows for both cell and tissue slide imaging and processing.

Designed for routine clinical use, the system can identify M-proteins based on their molecular weight to help diagnose multiple myeloma and related disorders.

Legislation passed by the US Senate to reopen the federal government includes a temporary delay to price cuts and data reporting requirements.

NEW YORK – Precision oncology firm Personalis announced on Monday that its NeXT Personal test for minimal residual disease has received coverage from the US Centers for Medicare and Medicaid Services ...

Last week, readers were most interested in a story about how Siemens Healthineers is preparing for possible changes by its parent firm.